>中东和非洲伤口护理生物制剂市场,按产品(生物皮肤替代品、外用药物、合成皮肤移植、生长因子、同种异体移植和异种移植)、伤口类型(溃疡、手术和创伤性伤口、烧伤)、最终用户(医院、门诊手术中心、烧伤中心、伤口诊所等)、国家(南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)划分的行业趋势和预测到 2028 年
中东和非洲伤口护理生物制剂市场的市场分析和见解
预计伤口护理生物制剂市场在 2021 年至 2028 年的预测期内将以 6.3% 的速度增长。Data Bridge Market Research 关于伤口护理生物制剂市场的报告提供了有关预测期内预计普遍存在的各种因素的分析和见解,同时提供了它们对市场增长的影响。足部溃疡发病率的增加、烧伤病例发病率的增加、人口老龄化和伤口护理生物制剂的创新是伤口护理生物制剂市场增长的主要因素。
伤口护理生物制剂医疗用于下肢伤口。伤口护理生物制剂是用于治疗难愈合伤口的生物工程产品。
伤口护理治疗和管理计划的增加是推动伤口护理生物制剂市场增长的主要因素之一。由于肥胖、不健康饮食和缺乏运动,糖尿病发病率增加,这将进一步加速伤口护理生物制剂市场的增长率。对开发更好治疗方案的重视,加上医疗保健领域的技术进步,将进一步创造有利可图的市场增长机会。此外,医疗保健基础设施的改善、生物技术领域投资的增加以及医疗保健支出的激增,对伤口护理生物制剂市场价值产生了积极影响。
另一方面,伤口治疗和伤口护理生物制剂的高成本预计会阻碍市场的增长。皮肤替代品失效的风险预计将对伤口护理生物制剂市场的增长率构成挑战。与皮肤移植和替代品相关的产品故障、产品召回和高拒收率的增加将进一步阻碍市场增长率。
This wound care biologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on wound care biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Middle East and Africa Wound Care Biologics Market Scope and Market Size
The wound care biologics market is segmented on the basis of product, wound type and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of the product, the wound care biologics market is segmented into biologic skin substitutes, topical agents, synthetic skin grafts, growth factors, allografts and xenografts. Biologic skin substitutes are further segmented into human donor tissue-derived products, acellular animal-derived products and biosynthetic products.
- On the basis of the wound type, the wound care biologics market is segmented into ulcers, surgical and traumatic wounds and burns. Ulcers venous are further segmented into ulcers, diabetic foot ulcers, pressure ulcers and other ulcers.
- On the basis of end users, the market is segmented into hospitals, ambulatory surgical centers, burn centers, wound clinics and others.
Middle East and Africa Wound Care Biologics Market Country Level Analysis
The wound care biologics market is analyzed and market size insights and trends are provided by country, product, wound type and end users as referenced above.
The countries covered in the wound care biologics market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East & Africa (MEA) as a part of Middle East & Africa (MEA).
Middle East and Africa region dominates due to rising prevalence of chronic and non-healing wounds, skin ulcers and burns have been driving the market growth in this region. Rising geriatric population coupled with rising innovation in the wound care biologics have further generated lucrative market growth opportunities.
伤口护理生物制剂市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
中东和非洲伤口护理生物制剂市场还为您提供每个国家/地区资本设备医疗保健支出增长、伤口护理生物制剂市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对中东和非洲伤口护理生物制剂市场的影响的详细市场分析。数据适用于 2010-2019 年的历史时期。
竞争格局和中东和非洲伤口护理生物制剂市场份额分析
伤口护理生物制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对伤口护理生物制剂市场的关注有关。
伤口护理生物制剂市场报告中涉及的主要参与者包括 Smith & Nephew plc、Mölnlycke Health Care AB.、Integra LifeSciences Corporation、Wright Medical Group NV、Zimmer Biomet、Anika Therapeutics、solsys、Anika Therapeutics, Inc.、Osiris Therapeutics, Inc.、Kerecis.、ACell Inc. 和 Marine Polymer Technologies, Inc.,以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
TABLE OF CONTENTS MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.2 DBMR MARKET CHALLENGE MATRIX
2.3 SECONDARY SOURCES
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING CASES OF DIABETIC FOOT ULCERS
3.1.2 INCREASING INCIDENCES OF BURN CASES
3.1.3 RISING NUMBER OF GERIATRIC POPULATION
3.1.4 INNOVATION IN WOUND CARE BIOLOGICS
3.1.5 NEW PRODUCT LAUNCHES
3.2 RESTRAINS
3.2.1 HIGH COST OF WOUND TREATMENT AND WOUND CARE BIOLOGICS
3.2.2 RISK OF SKIN SUBSTITUE FAILURE
3.3 OPPORTUNITIES
3.3.1 3D SKIN PRINTING
3.3.2 AWARENESS PROGRAMS
3.4 CHALLENGES
3.4.1 LACK OF WOUND MANAGEMENT SERVICES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SYNTHETIC SKIN GRAFTS
6.3 GROWTH FACTORS
6.3.1 PLATELET DERIVED GROWTH FACTOR (PDGF)
6.3.2 PLATELET RICH PLASMA (PRP)
6.3.3 EPIDERMAL GROWTH FACTORS (EGF)
6.3.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
6.3.5 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
6.3.6 TALACTOFERRIN ALFA
6.3.7 THROMBIN PEPTIDE
6.3.8 KERATINOCY GROWTH FACTOR (KGF)
6.4 ALLOGRAFTS
6.5 XENOGRAFTS
7 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE
7.1 OVERVIEW
7.2 WOUNDS
7.2.1 SURGICAL WOUND
7.2.1.1 SKIN SURGERY
7.2.1.1.1 WOUND CLOSURE
7.2.1.1.2 SKIN BIOPSY
7.2.1.1.3 SKIN FLAP
7.2.1.1.4 SKIN GRAFT
7.2.1.1.5 OTHERS
7.2.1.2 COSMETIC PROCEDURE
7.2.1.2.1 BREST ENHANCEMENT
7.2.1.2.2 FACIAL CONTOURING
7.2.1.2.3 FACIAL REJUVENATION:
7.2.1.2.4 BODY CONTOURING
7.2.1.2.5 SKIN REJUVENATION
7.2.1.2.6 OTHERS
7.2.1.3 GYNECOLOGIC PROCEDURES
7.2.1.3.1 PUBOVAGINALIS SLING
7.2.1.3.2 PELVIC FLOOR RECONSTRUCTION
7.2.1.3.3 RECTOCELE REPAIR SURGERY
7.2.1.3.4 OTHERS
7.2.1.4 GASTROINTESTINAL PROCEDURE
7.2.1.4.1 GENERAL GASTROINTESTINAL SURGERY
7.2.1.4.2 HERNIA
7.2.1.4.3 OTHERS
7.2.2 ACUTE WOUNDS
7.2.3 CHRONIC WOUNDS
7.2.4 TRAUMATIC WOUNDS
7.3 BURNS
7.3.1 ULCERS
7.3.2 DIABETIC ULCERS
7.3.3 PRESSURE ULCER
7.3.4 VENOUS ULCER
7.3.5 OTHERS
8 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 WOUND CARE CENTERS
8.4 AMBULATORY SURGICAL CENTERS
8.5 CLINICS
8.6 COMMUNITY HEALTHCARE CENTER
9 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: GEOGRAPHY
9.1 MIDDLE EAST & AFRICA
9.1.1 SOUTH AFRICA
9.1.2 REST OF MIDDLE EAST & AFRICA
10 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
11 COMPANY PROFILE
11.1 MIMEDX.
11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS:
11.1.3 COMPANY SHARE ANALYSIS:
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENTS
11.2 ORGANOGENESIS INC
11.2.1 COMPANY OVERVIEW
11.2.2 GEOGRAPHIC PRESENCE
11.2.3 COMPANY SHARE ANALYSIS:
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENTS
11.3 INTEGRA LIFESCIENCES
11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS:
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 CONVATEC INC.
11.4.1 COMPANY OVERVIEW
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS:
11.4.4 PRODUCT PORTFOLIO :
11.4.5 RECENT DEVELOPMENTS
11.5 ACELL INC.
11.5.1 COMPANY OVERVIEW
11.5.2 PRODUCT PORTFOLIO
11.5.3 RECENT DEVELOPMENTS
11.6 ALLOSOURCE
11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS
11.7 ALPHATEC SPINE, INC. ( A SUBSIDARY OF ALPHATEC HOLDINGS, INC)
11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 AMNIO TECHNOLOGY, LLC
11.8.1 COMPANY OVERVIEW
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 AMNIOX MEDICAL, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS
11.10 ANIKA THERAPEUTICS, INC.
11.10.1 COMPANY OVERVIEW
11.10.2 REVENUE ANALYSIS
11.10.3 PRODUCT PORTFOLIO
11.10.4 RECENT DEVELOPMENTS
11.11 BIOHORIZONS IPH, INC ( A SUBSIDARY OF HENRY SCHEIN, INC.)
11.11.1 COMPANY OVERVIEW
11.11.2 GEOGRAPHICPRESENCE
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS
11.12 KERECIS
11.12.1 COMPANY OVERVIEW
11.12.2 GEOGRAPHICAL PRESENCE
11.12.3 PRODUCT PORTFOLIO
11.12.4 RECENT DEVELOPMENTS
11.13 MARINE POLYMER TECHNOLOGIES, INC
11.13.1 COMPANY OVERVIEW
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 MÖLNLYCKE HEALTH CARE AB
11.14.1 COMPANY OVERVIEW
11.14.2 REVENUE ANALYSIS
11.14.3 PRODUCT PORTFOLIO
11.14.4 RECENT DEVELOPMENTS
11.15 OSIRIS THERAPEUTICS, INC.
11.15.1 COMPANY OVERVIEW
11.15.2 REVENUE ANALYSIS
11.15.3 PRODUCT PORTFOLIO
11.15.4 RECENT DEVELOPMENTS
11.16 SKYE BIOLOGICS INC.
11.16.1 COMPANY OVERVIEW
11.16.2 PRODUCT PORTFOLIO :
11.16.3 RECENT DEVELOPMENT:
11.17 SMITH AND NEPHEW
11.17.1 COMPANY OVERVIEW
11.17.2 REVENUE ANALYSIS
11.17.3 PRODUCT PORTFOLIO
11.17.4 RECENT DEVELOPMENTS
11.18 SOLSYS MEDICAL.
11.18.1 COMPANY OVERVIEW
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENTS
11.19 VERICEL CORPORATION.
11.19.1 COMPANY OVERVIEW
11.19.2 1.1.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.20 WRIGHT MEDICAL GROUP N.V
11.20.1 COMPANY OVERVIEW
11.20.2 1.1.2 REVENUE ANALYSIS
11.20.3 PRODUCT PORTFOLIO
11.20.4 RECENT DEVELOPMENTS
12 RELATED REPORTS
表格列表
LIST OF TABLES MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET
TABLE 1 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 2 MIDDLE EAST-AND AFRICA SYNTHETIC SKIN GRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 3 MIDDLE EAST-AND AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 4 MIDDLE EAST-AND AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 5 MIDDLE EAST-AND AFRICA ALLOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 6 MIDDLE EAST-AND AFRICA XENOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 7 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2015– 2025 (USD MILLION)
TABLE 8 MIDDLE EAST-AND AFRICA WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 9 MIDDLE EAST-AND AFRICA WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016– 2025 (USD MILLION)
TABLE 10 MIDDLE EAST-AND AFRICA SURGICAL WOUND IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 11 MIDDLE EAST-AND AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 12 NUMBER OF COSMETIC SURGERY, 2016 & 2017
TABLE 13 MIDDLE EAST-AND AFRICA COSMETIC SURGERY IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 14 MIDDLE EAST-AND AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 15 MIDDLE EAST-AND AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2018-2025 (USD MILLION)
TABLE 16 MIDDLE EAST-AND AFRICA BURNS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 17 MIDDLE EAST-AND AFRICA ULCERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 18 MIDDLE EAST-AND AFRICA ULCERS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2016-2025 (USD MILLION)
TABLE 19 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY END USER, 2016 – 2025 (USD MILLION)
TABLE 20 MIDDLE EAST-AND AFRICA HOSPITALS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 21 MIDDLE EAST-AND AFRICA WOUND CARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 22 STATISTICS FOR AMBULATORY SURGICAL CENTER. U.S.
TABLE 23 MIDDLE EAST-AND AFRICA AMBULATORY SURGICAL CENTERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 24 MIDDLE EAST-AND AFRICA CLINICS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 25 MIDDLE EAST-AND AFRICA COMMUNITY HEALTHCARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 27 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 38 SOUTH AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 39 SOUTH AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 40 SOUTH AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 41 SOUTH AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 42 SOUTH AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 43 SOUTH AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 44 SOUTH AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 45 SOUTH AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 46 SOUTH AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 47 SOUTH AFRICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 48 SOUTH AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 49 REST OF MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
图片列表
LIST OF FIGURES MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET
FIGURE 1 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: RESEARCH SNAPSHOT
FIGURE 4 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: BOTTOM UP APPROACH
FIGURE 5 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: TOP DOWN APPROACH
FIGURE 6 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 1 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: DBMR MARKET POSITION GRID
FIGURE 2 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET
FIGURE 4 AGING POPULATION IN DIFFERENT COUNTRIES (2014, 2017 & 2020)
FIGURE 5 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 6 INCREASING PREVELANCE OF DIABETIC FOOT ULCERS AND INCREASING INCIDENCES OF BURN CASES ARE EXPECTED TO DRIVE THE MARKET FOR MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS IN THE FORECAST PERIOD 2018 TO 2025
FIGURE 7 SYNTHETIC SKIN GRAFTS IN MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET IN 2018 & 2025
FIGURE 8 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
FIGURE 9 WORLDWIDE PREVALENCE OF VARIOUS WOUND TYPES, 2011
FIGURE 10 CASES OF BURN INJURIES, (2009 – 2012)
FIGURE 11 PREVALENCE OF PRESSURE ULCERS IN FEW COUNTRIES
FIGURE 12 NUMBER OF SURGICAL PROCEDURES AND SURGICAL SITE INFECTIONS
FIGURE 13 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: BY PRODUCT TYPE, 2017
FIGURE 14 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: BY WOUND TYPE, 2017
FIGURE 15 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: BY END USER, SNAPSHOT 2017
FIGURE 16 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 17 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 18 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 19 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 20 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 21 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.